- জেনেরিক নাম
- Rivaroxaban
- শক্তি
- 2.5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Opsonin Pharma Limited
৳ ৭.৮৪ ৳ ৮ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
বাংলাদেশে XARELTA 2.5 Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Rivaroxaban আছে (২.৫ mg)। এই ব্র্যান্ডের প্রস্তুতকারক Opsonin Pharma Limited। দাম: প্রতি ইউনিট ৮ টাকা। XARELTA 2.5-এর সাথে Rivaroxaban-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Rivaroxaban-এর ১৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১টি। সবচেয়ে কম দাম Rivadel 2.5 Tablet-এর, প্রতি ইউনিট ৳ ৫।
XARELTA 2.5 is a tablet from Opsonin Pharma Limited, with the generic name Rivaroxaban. XARELTA 2.5 is a film-coated tablet that contains Rivaroxaban 2.5 mg. Because this medicine affects clotting, it should only be taken on a doctor's advice, and the doctor chooses the dose and how long it is used. Use it only as your doctor directs.
It is an oral anticoagulant, sometimes called a blood thinner. XARELTA 2.5 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism. It is an oral anticoagulant and is not meant for self-treatment. Always follow your doctor's advice about why and for how long you need it.
The tablet is swallowed, and the doctor will say whether to take it with food and at what time of day. XARELTA 2.5 is taken by mouth. Swallow the tablet with water. Do not take more than prescribed. If you forget a dose, ask your doctor or pharmacist what to do.
Call your doctor promptly if you notice unusual or prolonged bleeding, or any sign of neurological problems such as weakness or numbness. The most common side effect of Rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop. Bleeding may appear as bruising, nosebleeds, gum bleeding or blood in the urine or stool, and in some cases it can be serious. Tell your doctor promptly about any unusual or persistent bleeding, or any new symptoms.
It is a pregnancy category C medicine, and there are no adequate studies in pregnancy or breastfeeding, so tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Rivaroxaban is a pregnancy category C medicine, and dosing in pregnancy has not been established; it is not known whether it passes into breast milk, and safety in breastfeeding has not been established. Tell your doctor about all the other medicines you take.
It is an oral anticoagulant, sometimes called a blood thinner. XARELTA 2.5 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism.
The tablet is swallowed, and the doctor will say whether to take it with food and at what time of day. XARELTA 2.5 is taken by mouth.
Call your doctor promptly if you notice unusual or prolonged bleeding, or any sign of neurological problems such as weakness or numbness. The most common side effect of Rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop.
It is a pregnancy category C medicine, and there are no adequate studies in pregnancy or breastfeeding, so tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Rivaroxaban is a pregnancy category C medicine, and dosing in pregnancy has not been established; it is not known whether it passes into breast milk, and safety in breastfeeding has not been established.
৳ ৭.৮৪ ৳ ৮ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।